The comprehensive healthcare company SCL Group is establishing a cooperative framework with Indonesia’s National Central General Hospital, accelerating its entry into the Southeast Asian medical market. Market attention is focusing on the potential for local commercialization centered on precision diagnostics and AI-based medical solutions.

SCL Group announced on the 28th that it had signed a memorandum of understanding (MOU) with Indonesia’s National Central General Hospital RSUP Cipto Mangunkusumo (Cipto Mangunkusumo National Central General Hospital, RSCM) for cooperation in advanced medical services and diagnostic fields. RSCM is Indonesia’s representative national central general hospital and this is the first case of cooperation with a Korean medical institution in the field of laboratory medicine.

Under this agreement, the two institutions will pursue collaboration in medium- to long-term projects including precision diagnostics such as multi-cancer early screening and genetic testing, AI-based early diagnosis solutions, joint use of medical equipment such as MRI and CT, and K-healthcare platforms.

In particular, services focused on early diagnosis and preventive medicine are considered high-demand areas in the Indonesian market. Once commercialization is fully underway, revenue models are expected to be formed across a range of areas including diagnostic testing services, health checkup programs, and data-based medical platforms.

● Cooperation centered on precision diagnostics and health checkups…bridgehead for expansion into the Southeast Asian market

SCL Group Chairman Lee Kyung-ryul stated, “On the occasion of the Korea-Indonesia summit, discussions have been held on AI-based medical accessibility and public health cooperation measures,” adding, “This agreement will serve as an opportunity to lead to tangible outcomes in medical cooperation between the two countries.” He further emphasized, “It will become a foundation for expanding a medical network across Southeast Asia beyond Indonesia.”

RSCM Hospital Director Supriyanto Darmorejo said, “A cooperation base will be established in the fields of precision diagnostics and preventive medicine,” and added, “We look forward to even greater expansion in the exchange of medical technology and services.”

The signing ceremony was held on the 27th at RSCM Hospital in Jakarta, with more than 100 participants from the medical communities and governments of both countries. Yoon Soon-gu, Ambassador of the Republic of Korea to Indonesia, expressed his support, stating, “This agreement is the starting point of cooperation to apply Korea’s advanced diagnostic technology to Indonesia’s medical system.”

SCL Group operates healthcare affiliates focused on diagnostic testing and health checkups, and runs the local screening center “K-LAB” in Indonesia through its affiliate Hanaro Medical Foundation. Leveraging this agreement, the company plans to expand cooperation with local medical institutions and accelerate the establishment of a Southeast Asian medical network.

Popular News